ATE177102T1 - Chromanderivate - Google Patents

Chromanderivate

Info

Publication number
ATE177102T1
ATE177102T1 AT96307772T AT96307772T ATE177102T1 AT E177102 T1 ATE177102 T1 AT E177102T1 AT 96307772 T AT96307772 T AT 96307772T AT 96307772 T AT96307772 T AT 96307772T AT E177102 T1 ATE177102 T1 AT E177102T1
Authority
AT
Austria
Prior art keywords
chromeder
derivatives
chromeder derivatives
Prior art date
Application number
AT96307772T
Other languages
English (en)
Inventor
Gary Paul Stack
Richard Eric Mewshaw
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE177102T1 publication Critical patent/ATE177102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96307772T 1995-11-06 1996-10-28 Chromanderivate ATE177102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US730795P 1995-11-06 1995-11-06

Publications (1)

Publication Number Publication Date
ATE177102T1 true ATE177102T1 (de) 1999-03-15

Family

ID=21725405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96307772T ATE177102T1 (de) 1995-11-06 1996-10-28 Chromanderivate

Country Status (22)

Country Link
EP (1) EP0771801B1 (de)
JP (1) JPH09169764A (de)
KR (1) KR970027086A (de)
CN (1) CN1083843C (de)
AR (1) AR004523A1 (de)
AT (1) ATE177102T1 (de)
AU (1) AU701636B2 (de)
BR (1) BR9605437B1 (de)
CA (1) CA2189525C (de)
CZ (1) CZ286649B6 (de)
DE (1) DE69601611T2 (de)
DK (1) DK0771801T3 (de)
ES (1) ES2128145T3 (de)
GR (1) GR3030132T3 (de)
HU (1) HUP9603058A3 (de)
IL (1) IL119483A (de)
MX (1) MX9605369A (de)
NO (1) NO964684L (de)
NZ (1) NZ299680A (de)
SK (1) SK281085B6 (de)
TW (1) TW467914B (de)
ZA (1) ZA969191B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT923576E (pt) * 1996-08-27 2003-02-28 Wyeth Corp Derivados de 4-amino-etoxi-indolona como agonistas de dopamina d2
JP2001502327A (ja) * 1996-10-15 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション ２，３，８，９―テトラヒドロ―７Ｈ―１，４―ジオキシノ［２，３―ｅ］インドール―８―オンのアザヘテロサイクリルメチル誘導体
CN1138761C (zh) * 1997-02-18 2004-02-18 惠氏公司 4－氨基烷氧基－1,3－二氢苯并咪唑－2－酮衍生物、它们的制备方法以及它们作为多巴胺自身受体（d2）激动剂的用途
US5990144A (en) * 1997-02-18 1999-11-23 American Home Products Corporation 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists
US6541502B1 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541501B2 (en) * 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
TW200811182A (en) 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
EP1123933A1 (de) * 1994-10-14 2001-08-16 MERCK PATENT GmbH ZNS wirksames 2-[5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl]chroman

Also Published As

Publication number Publication date
AR004523A1 (es) 1998-12-16
SK141396A3 (en) 1997-05-07
SK281085B6 (sk) 2000-11-07
ES2128145T3 (es) 1999-05-01
HK1010104A1 (en) 1999-06-11
ZA969191B (en) 1998-04-30
HUP9603058A2 (en) 1997-05-28
CA2189525A1 (en) 1997-05-07
BR9605437B1 (pt) 2009-08-11
GR3030132T3 (en) 1999-07-30
DE69601611D1 (de) 1999-04-08
MX9605369A (es) 1997-05-31
HUP9603058A3 (en) 1998-12-28
HU9603058D0 (en) 1996-12-30
AU7055496A (en) 1997-05-15
KR970027086A (ko) 1997-06-24
CN1151989A (zh) 1997-06-18
EP0771801B1 (de) 1999-03-03
CN1083843C (zh) 2002-05-01
AU701636B2 (en) 1999-02-04
CZ286649B6 (cs) 2000-05-17
CA2189525C (en) 2006-04-25
IL119483A (en) 1999-06-20
TW467914B (en) 2001-12-11
EP0771801A1 (de) 1997-05-07
NO964684D0 (no) 1996-11-05
DK0771801T3 (da) 1999-09-27
JPH09169764A (ja) 1997-06-30
NZ299680A (en) 1998-05-27
NO964684L (no) 1997-05-07
CZ324096A3 (en) 1997-12-17
DE69601611T2 (de) 1999-10-21
BR9605437A (pt) 1998-08-04
IL119483A0 (en) 1997-01-10

Similar Documents

Publication Publication Date Title
DE69611361D1 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO964667D0 (no) Purin-6-on-derivater
DE69605810D1 (de) Hubtor
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
DE69618366D1 (de) Wellpappebögenkaschiermaschine
DE69605312D1 (de) Rettungsflösse
PT856007E (pt) Derivados de ciclopeptidos
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
DE59610613D1 (de) Leibungsbefestigungswinkel
NO961404D0 (no) 4-indolylpiperazinyl-derivater
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
DK0843675T3 (da) Aza-anthracyclinonderivater
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
DE69620514D1 (de) 5-aminoflavon-derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee